| answer text |
<p>On 27 June, the PM told Global Citizen’s international summit that world leaders
have a moral duty to ensure that vaccines, treatments and tests are truly available
to all. We are working with international partners, including industry, to agree collaborative
approaches to supporting vaccine development, manufacturing scale-up and future distribution
to meet both domestic and international needs.</p><p>The Coalition for Epidemic Preparedness
Innovations (CEPI), to which we have provided £250 million this year, is committed
to ensuring that appropriate vaccines are available to populations when and where
they are needed, regardless of a country's ability to pay. CEPI selects vaccines for
its portfolio based on their potential for success, rapid development and scalability.
CEPI negotiates global access requirements as part of its funding agreements.</p><p>Through
the COVAX partnership, under the Access to Covid Tools (ACT)-Accelerator, CEPI, Gavi,
the Vaccine Alliance, and the World Health Organization are working together to ensure
that the vaccines are affordable and available equitably. As part of this, Gavi’s
Advance Market Commitment (AMC) will incentivise vaccine manufacturers to produce
sufficient quantities of eventual COVID-19 vaccines and to ensure access for LMICs.
The UK has contributed £48 million to the AMC.</p>
|
|
